Garmin Soars 23% with New Smartwatches; Dell and Abbvie Make Strategic Moves
Wednesday, Oct 30, 2024 6:30 pm ET
1min read 1. Garmin Ltd. (NYSE: GRMN)
Garmin Ltd. surged by 23.21%. Garmin will announce its Q3 2024 financial results on October 30. Recently, Garmin recalled 632 fitness bikes due to component issues and introduced new Tactix 8 AMOLED and Fenix 8 smartwatches. Tigress Financial maintains a strong buy rating, targeting a price of $215.
2. Vulcan Materialsmpany (NYSE: VMC)
Vulcan Materialsmpany surged by 6.41%. Vulcan Materials reported its third quarter fiscal 2024 results on October 30, with Barclays maintaining an overweight rating and setting a price target of $285. JP Morgan rated it neutral with a price target of $245. Insider transactions were disclosed in August.
3. Dell Technologies (NYSE: DELL)
Dell Technologies surged by 6.4%. Dell Technologies' PowerScale storage is certified for enhanced productivity; PowerMax upgrades enhance efficiency, security, and cloud agility with new direct backup capabilities. Recognized as a Forbes 2024 Global Best Employer, Dell fosters an inclusive culture and supports data center sustainability.
4. Abbvie (NYSE: ABBV)
Abbvie surged by 6.39%. Abbvie has acquired Aliada Therapeutics for $1.4 billion, aiming to enhance neuroscience capabilities. The transaction is expected to conclude in Q4 2024, subject to regulatory approval. Additionally, Citigroup maintains a buy rating on Abbvie with a price target of $215.
5. Verisk Analytics (Nasdaq: VRSK)
Verisk Analytics gained solidly by 4.54%. Verisk Analytics reported its Q3 2024 financial results, with prior revenue of $1.421 billion, up 7.1%. RBC Capital maintains an Outperform rating with a $300 target. Evercore ISI Group targets $279. Recent insider trading includes sales by executives Mann Elizabeth and Liss Samuel G.
Garmin Ltd. surged by 23.21%. Garmin will announce its Q3 2024 financial results on October 30. Recently, Garmin recalled 632 fitness bikes due to component issues and introduced new Tactix 8 AMOLED and Fenix 8 smartwatches. Tigress Financial maintains a strong buy rating, targeting a price of $215.
2. Vulcan Materialsmpany (NYSE: VMC)
Vulcan Materialsmpany surged by 6.41%. Vulcan Materials reported its third quarter fiscal 2024 results on October 30, with Barclays maintaining an overweight rating and setting a price target of $285. JP Morgan rated it neutral with a price target of $245. Insider transactions were disclosed in August.
3. Dell Technologies (NYSE: DELL)
Dell Technologies surged by 6.4%. Dell Technologies' PowerScale storage is certified for enhanced productivity; PowerMax upgrades enhance efficiency, security, and cloud agility with new direct backup capabilities. Recognized as a Forbes 2024 Global Best Employer, Dell fosters an inclusive culture and supports data center sustainability.
4. Abbvie (NYSE: ABBV)
Abbvie surged by 6.39%. Abbvie has acquired Aliada Therapeutics for $1.4 billion, aiming to enhance neuroscience capabilities. The transaction is expected to conclude in Q4 2024, subject to regulatory approval. Additionally, Citigroup maintains a buy rating on Abbvie with a price target of $215.
5. Verisk Analytics (Nasdaq: VRSK)
Verisk Analytics gained solidly by 4.54%. Verisk Analytics reported its Q3 2024 financial results, with prior revenue of $1.421 billion, up 7.1%. RBC Capital maintains an Outperform rating with a $300 target. Evercore ISI Group targets $279. Recent insider trading includes sales by executives Mann Elizabeth and Liss Samuel G.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.
